A prospective, randomized controlled trial for aura intervention in the control of temporal lobe epilepsy

Study for the effects of non-invasive aura intervention in the control of temporal lobe epilepsy

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000032517

Enrollment

Unknown

Registered

2020-05-01

Start date

2020-06-01

Completion date

Unknown

Last updated

2020-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

temporal lobe epilepsy

Interventions

Experimental Group:aura intervention

Control Group:Nil

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. aged over 18 years; 2. reliable clinical and EEG evidence confirming the diagnosis of temporal lobe epilepsy; 3. average seizure frequency of at least once per month for at least 1 year; 4. having experienced auras; 5. ability to understand and follow instruction; 6. unchanged anticonvulsant ordination for at least 1 month prior to participation and no ongoing psychopharmacological treatment.

Exclusion criteria

Exclusion criteria: 1. widely fructuating seizure frequency or history of recurrent status epilepticus; 2. participants taking with more than two anticonvulsant medications; 3. serious other medical problems such as brain tumors, cancer, stroke, significant heart disease, or psychiatric disorders such as schizophrenia or major depression; 4. progressive epilepsy.

Design outcomes

Primary

Measure	Time frame
Changes in seizure frequency;	—

Secondary

Measure	Time frame
Quality of life;	—

Countries

China

Contacts

Public ContactJun Wang

Nanfang Hospital, Southern Medical University

smuwangjun@163.com+86 020-61641804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026